**Chapter 6**

*The Recent Topics in Genetic Polymorphisms*

[30] Chen H, Lum A, Seifried A, Wilkens LR, Le Marchand L. Association of the NAD(P)H: Quinone oxidoreductase 609**→**C T polymorphism with a decreased lung cancer risk. Cancer Research.

[31] Song P, Li K, Liu L, Wang X, Jian Z, Zhang W, et al. Genetic polymorphism of the Nrf2 promoter region is associated with vitiligo risk in Han Chinese populations. Journal of Cellular and Molecular Medicine. 2016;**20**(10):1840-1850. DOI: 10.1111/

[32] Kowalski M, Przybylowska K, Rusin P, Olszewski J, Morawiec-

[33] Le Marchand L, Donlon T,

Lum-Jones A, Seifried A, Wilkens LR. Association of the hOGG1 Ser326Cys polymorphism with lung cancer risk. Cancer Epidemiology, Biomarkers and Prevention. 2002;**11**(4):409-412

[34] Chiarella P, Capone P, Carbonari D, Sisto R. A predictive model assessing the genetic susceptibility risk at workplace. International Journal of Environmental Research and Public Health. 2019;**16**:2012. DOI: 10.3390/

[35] Kelada SN, Eaton DL, Wang SS, Rothman NR, Khoury MJ. The role of genetic polymorphisms in environmental health. Environmental

Health Perspectives. 2003;**111**: 1055-1064. DOI: 10.1289/ehp.6065

Sztandera A, Bielecka-Kowalska A, et al. Genetic polymorphisms in DNA base excision repair gene XRCC1 and the risk of squamous cell carcinoma of the head and neck. Journal of Experimental and Clinical Cancer Research. 2009;**28**:37. DOI: 10.1186/1756-9966-28-37

2000;**60**(3):644-649

1999;**59**(13):3045-3048

jcmm.12874

myeloperoxidase gene. Cancer Research.

**80**

ijerph16112012
